For women, the NREGA would bring important social gains   Not being an expert on the subject and too lazy to read all the fine print, I do not know the exact allocations under the Mahatma Gandhi National Rural Employment Guarantee Act this year. But I gather the money has been cut down, largely because the sums allocated last year were not fully used by most states. Maybe there were other considerations...

The Supreme Court has handed down an extraordinary decision with some extraordinary arguments directing the central government to execute the “river interlinking project”. How could the Court which says “it can hardly take unto itself tasks of making of a policy decision or planning for the country on the need for acquisition and construction of river linking channels” then go on to actually take the very same policy decision and...

According to the WHO, TB is the third leading cause of death for women aged 15-44 worldwide.   When did we last consider TB as one of India’s biggest health problems? To refresh memories, here are a few forgotten facts about TB in India: one of the leading causes of death in India, TB kills one person every two minutes and 750 people every day. The direct and indirect annual costs of...

The Budget provides proof of the United Progressive Alliance government having forgotten the importance of its own “flagship schemes”. BUDGET 2012-13 provides conclusive proof that the United Progressive Alliance (UPA) government has lost its way. It has managed the remarkable feat of upsetting almost everyone and making no one happy. The Budget is highly regressive in both taxation and spending terms and will raise prices of essentials, so aam aurat and...

-Economic and Political Weekly The compulsory licence for Nexavar is only the beginning of a new battle over drug prices. The grant of a compulsory licence (CL) to Natco Pharma, a relatively small Indian pharmaceutical company, to manufacture and sell the cancer drug sorafenib (Nexavar) has been rightly hailed as a major step forward for public health and the wider availability of life saving medicines.   The German pharmaceutical company Bayer holds the patent...